Avantax Planning Partners’s Bio-Techne TECH Stock Holding History

Avantax Planning Partners’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-20	Closed	-$1K	–	1338
2018 Q1	$1K	Buy	+20	New	+$707	﹤0.01%	1753

Other funds holding TECH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Avantax Planning Partners's TECH Position: Q2 2018 in Review

Avantax Planning Partners sold out of Bio-Techne (TECH) in Q2 2018, closing a stake of 20 shares — an estimated $1K sold.

Avantax Planning Partners first reported a position in TECH in Q1 2018 and held it in 1 quarter. The position peaked at $1K in Q1 2018. 341 funds tracked by Wall St. Rank hold TECH as of Q2 2018.

Avantax Planning Partners reported no remaining Bio-Techne position as of Q2 2018 after selling out during the quarter.
Avantax Planning Partners sold 20 Bio-Techne shares in Q2 2018, an estimated $1K.
Avantax Planning Partners first reported a position in Bio-Techne in Q1 2018 and held it in 1 quarter.
Avantax Planning Partners's Bio-Techne position peaked at $1K in Q1 2018.
341 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2018.

Based on Avantax Planning Partners's 13F filing for Q2 2018, filed 13 Aug 2018.